| Authors/Year | New treatments | Result/Observations |
| Liu et al., 2019 | Agglutinin + Horseradish peroxidase + Gold nanoparticles + Theophylline | Functional recovery of the phrenic nerve. |
| Lin et al., 2019 | Albumin nanoparticle + NEP1-40 peptide + Methylpredinisolone | Neuroprotection, anti-inflammation, neuroproliferation, antioxidation and reversal of damage from the primary lesion. |
| Fang et al., 2019 | AuNP + Juglans regia + Zonisamide | Selective cytotoxicity, high stability and controlled release. |
| Cox et al., 2020 | Nanoparticles of PLGA + E2 | Reduction of gliosis and neuroinhibitory factors and increase of growth factors and anti-inflammatory cytokines. |
| Robinson et al., 2020 | PLGA nanoparticles + SOD + Catalase | Reduction of chemical damage and significant systemic side effects. |
| Vismara et al., 2020 | NG + Rolipram | Selective cell action (A2) and increased motor performance. |